Again.. It is very hard to just by reading the improvement numbers from placebo to assess the drug's performance (15% over MMSE or ADCS-ADL 40% scores).  The fundamental question is the base in the placebo performance.  I looked up some sources on the internet and as far as I remember and my old posts confirmed this placebo … Continue reading The thorn in the side of $AVXL investors explained. BIIB037 vs. Anavex 2-73